ZEG:FRA
AstraZeneca PLC (US)
€149.80
arrow_upward
+1.56%(+2.30) 1D
Oct 19, 7:40:12 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEG...
Open
€146.25
High
€149.80
Low
€145.85
Mkt. cap
255.33B
Avg. vol.
904.00
Volume
863.00
52-wk high
€180.45
52-wk low
€134.00
No. of employees
96K
Open
€146.25
High
€149.80
Low
€145.85
Mkt. cap
255.33B
Avg. vol.
904.00
Volume
863.00
52-wk high
€180.45
52-wk low
€134.00
No. of employees
96K
News stories
From web sources and news partners
ad-hoc-news.de
·
5 hours ago
AstraZeneca stock: RBC keeps target at GBp 14,500 for AstraZeneca stock
Yahoo Finance
·
8 hours ago
AstraZeneca to present overall survival data from four pivotal Phase III trials in Presidential Symposia at ESMO 2026 featuring Sone-Ve, IMFINZI® (durvalumab), TAGRISSO® (osimertinib) and savolitinib
Traders Union
·
11 hours ago
AstraZeneca shares technical analysis: Downward price move meets GBX12,344 support
ad-hoc-news.de
·
12 hours ago
AstraZeneca signs USD 40 million AI deal. Citi targets AstraZeneca stock at GBp 18,600
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About AstraZeneca PLC (US)
CEOPascal Soriot
Employees96.1K
FoundedApr 6, 1999
HeadquartersCambridge, Cambridgeshire, United Kingdom
SectorPharmaceutical industry
Websiteastrazeneca.com